Indivior Pharmaceuticals Inc

INDVNASDAQHealthcare● Active

$37.86

+$0.24(+0.64%)

Market Cap$4.7B

P/E Ratio—

52W High$41

52W Low$13.42

Avg Volume2.6M

Open$37.70

Beta1.17

Net Income Financials Revenue

Indivior Pharmaceuticals Inc (INDV) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

INDV · net income · updated Jun 8, 2026

Core profitability metrics

INDV · net income · margin · TTM · CAGR

Net income was $210.0M for FY2025 (fiscal year ending 2025-12-31), up 10400.0% year-over-year. Net profit margin was 16.9%. Based on available data, Indivior Pharmaceuticals Inc has been profitable since at least 2016.

FY2025 Net Income$210.0M▲ +10400.0% YoY

Trailing 12M (TTM)$251.0Mtrailing 4 quarters sum

Net Profit Margin16.9%$210.0M ÷ $1.24B

YoY Change+10400.0%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2016

▸ FMP /income-statement · Annual · INDV net income history · INDV profit margin

Annual net income data

INDV · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025$210.0M▲ +10400.0%16.9%$1.24B

FY2024$2.0M▲ +101.6%0.2%$1.19B

FY2023Loss−$129.0M▼ 193.2%-11.8%$1.09B

FY2022Loss−$44.0M▼ 121.5%-4.9%$901.0M

FY2021$205.0M▲ +238.5%25.9%$791.0M

Net income vs peers (Healthcare)

INDV vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Indivior Pharmaceuticals IncYOU

INDV

$210.0M+10400.0%16.9%

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Indivior Pharmaceuticals Inc (INDV) reported net income of $210.0M for FY2025 (fiscal year ending 2025-12-31), up 10400.0% year-over-year. The net profit margin was 16.9% — meaning the company kept $0.17 of every dollar of revenue as profit.

Based on available data, Indivior Pharmaceuticals Inc has been profitable since at least 2016. Net income reached a peak of $262.7M in FY2018. Data available for 10 fiscal years.

Indivior Pharmaceuticals Inc's net profit margin was 16.9% for FY2025, based on the latest annual results.

Investors sometimes search for "Indivior Pharmaceuticals Inc net worth" — the company's market capitalization is a separate figure from INDV net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

INDV net income · 5 questions

Indivior Pharmaceuticals Inc is profitable. The company reported net income of $210.0M for FY2025, a net profit margin of 16.9%. Net income was up 10400.0% year-over-year. Based on available data, Indivior Pharmaceuticals Inc has been profitable since at least 2016.

is INDV profitabledoes INDV make a profitINDV profitabilityINDV profitable company

▸ Source: FMP /income-statement · GAAP · Indivior Pharmaceuticals Inc · Indivior Pharmaceuticals Inc SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026